Clinical Trial Update: High Dose Omega 3 in People at Risk for Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating high-dose omega-3 in people at risk for dementia; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognition Disorders
• Cognitive Disorders
• Dementia
• Mental Disorder
• Neurocognitive Disorders

Snippet

Sponsor: University Hospital, Akershus | Conditions: Dementia, Inflammation | Phase 2 | Status: UNKNOWN